[1]Arie J,Zukerman,Howard C,et al. Viral Hepatitis[M].Beijing: Science Press,2001:77-245.
[2]成军,孙关忠,陈瑜,等.高低浓度HBsAg血清中7项乙肝标志物的表现模式分析[J].细胞与分子免疫学杂志,2001,17(5):443-444.
[3]陈瑜,钟步云,徐根云,等.低水平血清乙肝病毒表面抗原测定及其临床意义[J].中华检验医学杂志,2001,24(1):39-41.
[4]Gall D,Nielsen K.Comparison of some methods for determing cutoff values for serological assays:a retrospective study using the fluorescence polarization assay[J].J Immunoassay Immunochem,2001,22(2):85-98.
[5]李金明.感染性疾病血清学检验中应重视对弱反应性标本的确认[J].中华检验医学杂志,2006,29(7):577-580.
[6]Resat O, Fehmi T, Veysel T,et al. Correlation of Quantitative Assay of HBsAg and HBV DNA Levels During Chronic HBV Treatment[J].Digestive Diseases and Sciences,2008,53(11):2995-2998.
[7]雷建华,杨旭,罗红雨,等.血清HBsAg和HBeAg阳性乙型肝炎患者HBsAg浓度与HBV复制水平的关系[J].中南大学学报(医学版),2006,31(4):548-551.
[8]Francis J,Mahoney .Update on diagnosis, management, and prevention of hepatitis B virus infection[J].Clini Microbiol Reviews,1999,12(2):351-366.
[9]Stefan M,Thomas B,Juergen R,et al. Hepatology[M]. Germany:Flying Publisher,2009:25-26.
[10]楼滨,周志东,范剑,等.血清乙型肝炎病毒表面抗原检测弱反应结果的确认方法及其评价[J].检验医学,2005,20(6):543-546.